BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc. 2000;75:355-359. [PMID: 10761489 DOI: 10.4065/75.4.355] [Cited by in Crossref: 195] [Cited by in F6Publishing: 162] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL. Hepatitis C virus infection and incident type 2 diabetes. Hepatology. 2003;38:50-56. [PMID: 12829986 DOI: 10.1053/jhep.2003.50291] [Cited by in Crossref: 270] [Cited by in F6Publishing: 243] [Article Influence: 15.0] [Reference Citation Analysis]
3 Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol. 2003;98:2751-2756. [PMID: 14687828 DOI: 10.1111/j.1572-0241.2003.08728.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 70] [Article Influence: 2.6] [Reference Citation Analysis]
4 Cai C, Zeng J, Wu H, Shi R, Wei M, Gao Y, Ma W. Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis. Exp Ther Med. 2015;10:693-698. [PMID: 26622377 DOI: 10.3892/etm.2015.2537] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
5 Mohamed MK. Risk factors for the development of diabetes mellitus in chronic HCV genotype 4 infection. J Gastroenterol Hepatol 2009;24:6-8. [PMID: 19196393 DOI: 10.1111/j.1440-1746.2008.05726.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Baid-Agrawal S, Frei U, Reinke P, Schindler R, Kopp MA, Martus P, Berg T, Juergensen JS, Anker SD, Doehner W. Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients. Am J Transplant. 2009;9:2777-2784. [PMID: 19845589 DOI: 10.1111/j.1600-6143.2009.02843.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
7 Patel S, Jinjuvadia R, Patel R, Liangpunsakul S. Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis. J Clin Gastroenterol 2016;50:80-4. [PMID: 26302498 DOI: 10.1097/MCG.0000000000000400] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
8 Lee S, Kim E, Jhun H, Hong J, Kwak A, Jo S, Bae S, Lee J, Kim B, Lee J, Youn S, Kim S, Kim M, Kim H, Lee Y, Choi DK, Kim YS, Kim S. Proinsulin Shares a Motif with Interleukin-1α (IL-1α) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1. J Biol Chem 2016;291:14620-7. [PMID: 27226621 DOI: 10.1074/jbc.M116.731026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
9 Zornitzki T, Malnick S, Lysyy L, Knobler H. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol 2015;21:233-9. [PMID: 25574096 DOI: 10.3748/wjg.v21.i1.233] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
10 Al-Anazi MR, Matou-Nasri S, Abdo AA, Sanai FM, Khan MQ, Albenmousa A, Al-Ashgar HI, Khalaf NZ, Al-Ahdal MN, Al-Qahtani AA. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia. BMC Infect Dis 2014;14:632. [PMID: 25551790 DOI: 10.1186/s12879-014-0632-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
11 Monago CC, Onwuka F, Osaro E. Effect of combined therapy of diabinese and nicotinic acid on liver enzymes in rabbits with dithizone-induced diabetes. J Exp Pharmacol 2010;2:145-53. [PMID: 27186100 DOI: 10.2147/JEP.S11490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Fabiani S, Fallahi P, Ferrari SM, Miccoli M, Antonelli A. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Rev Endocr Metab Disord. 2018;19:405-420. [PMID: 29322398 DOI: 10.1007/s11154-017-9440-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
13 Kuriyama S, Miwa Y, Fukushima H, Nakamura H, Toda K, Shiraki M, Nagaki M, Yamamoto M, Tomita E, Moriwaki H. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. J Clin Biochem Nutr 2007;40:116-22. [PMID: 18188413 DOI: 10.3164/jcbn.40.116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
14 Gastaldi G, Goossens N, Clément S, Negro F. Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review. J Adv Res 2017;8:149-59. [PMID: 28149650 DOI: 10.1016/j.jare.2016.11.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
15 Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol. 2006;12:6756-6765. [PMID: 17106922 DOI: 10.3748/wjg.v12.i42.6756] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 7.4] [Reference Citation Analysis]
16 Lonardo A, Carulli N, Loria P. HCV and diabetes. A two-question-based reappraisal. Dig Liver Dis. 2007;39:753-761. [PMID: 17611176 DOI: 10.1016/j.dld.2007.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
17 Kwon SY, Kim SS, Kwon OS, Kwon KA, Chung MG, Park DK, Kim YS, Koo YS, Kim YK, Choi DJ, Kim JH. Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus. Diabet Med 2005;22:1530-5. [PMID: 16241918 DOI: 10.1111/j.1464-5491.2005.01687.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126:586-597. [PMID: 14762795 DOI: 10.1053/j.gastro.2003.11.020] [Cited by in Crossref: 318] [Cited by in F6Publishing: 292] [Article Influence: 18.7] [Reference Citation Analysis]
19 Montenegro L, De Michina A, Misciagna G, Guerra V, Di Leo A. Virus C Hepatitis and Type 2 Diabetes: A Cohort Study in Southern Italy. American Journal of Gastroenterology 2013;108:1108-11. [DOI: 10.1038/ajg.2013.90] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
20 Huang JF, Yu ML, Dai CY, Chuang WL. Glucose abnormalities in hepatitis C virus infection. Kaohsiung J Med Sci. 2013;29:61-68. [PMID: 23347806 DOI: 10.1016/j.kjms.2012.11.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
21 Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes. 2014;5:586-600. [PMID: 25317237 DOI: 10.4239/wjd.v5.i5.586] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
22 Sabharwal S, Delgado-Borrego A, Chung RT. Extrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction. Liver Transpl. 2008;14 Suppl 2:S51-S57. [PMID: 18825714 DOI: 10.1002/lt.21613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
23 Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009;15:280-288. [PMID: 19140227 DOI: 10.3748/wjg.15.280] [Cited by in CrossRef: 196] [Cited by in F6Publishing: 163] [Article Influence: 16.3] [Reference Citation Analysis]
24 Poon RT, Fan ST, Wong J. Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol 2002;97:1480-8. [PMID: 12094870 DOI: 10.1111/j.1572-0241.2002.05792.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yagi S, Kaido T, Iida T, Yoshizawa A, Okajima H, Uemoto S. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surg Today. 2017;47:733-742. [PMID: 27837276 DOI: 10.1007/s00595-016-1444-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Cadranel JF, Di Martino V, Lambrey G, Mourlhon C, Nalet B, Anciaux ML, Richard C, Bigué JP, Barjon JN, Bories C, Barbare JC, Halimi C, Ribière O, Eugène C, Pauwels A, Jeanne S, Donato L, Dumouchel P, Pariente A, Duverlie G, Devergie B, Arlot S, Capron D. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. Eur J Gastroenterol Hepatol 2008;20:829-36. [PMID: 18794595 DOI: 10.1097/MEG.0b013e3282fc73a1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
27 Pereira TDSF, Pelinsari FCM, Ruas BM, Avelar LPP, da Fonseca VJ, de Abreu MHN, Salomão UE, Lima AS, de Souza e Silva ME, Gomez RS. Postoperative complications after dental extraction in liver pretransplant patients: DENTAL EXTRACTION IN LIVER PRETRANSPLANT PATIENTS. Spec Care Dentist 2016;36:277-81. [DOI: 10.1111/scd.12179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Helaly GF, Hussein NG, Refai W, Ibrahim M. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance. Translational Research 2011;158:155-62. [DOI: 10.1016/j.trsl.2011.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
29 D'Souza RF, Feakins R, Mears L, Sabin CA, Foster GR. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C. Aliment Pharmacol Ther 2005;21:519-24. [PMID: 15740534 DOI: 10.1111/j.1365-2036.2005.02382.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
30 Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev. 2006;22:274-283. [PMID: 16506276 DOI: 10.1002/dmrr.636] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
31 Imafuku S, Nakayama J. Profile of patients with psoriasis associated with hepatitis C virus infection. J Dermatol. 2013;40:428-433. [PMID: 23414394 DOI: 10.1111/1346-8138.12112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
32 Khan R, Foster GR, Chowdhury TA. Managing diabetes in patients with chronic liver disease. Postgrad Med. 2012;124:130-137. [PMID: 22913901 DOI: 10.3810/pgm.2012.07.2574] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
33 Parise ER, Oliveira AC. [Insulin resistance in chronic hepatitits C]. Arq Gastroenterol. 2007;44:178-184. [PMID: 17962866 DOI: 10.1590/S0004-28032007000200017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 García-compean D, Jaquez-quintana JO, Maldonado-garza H. Hepatogenous diabetes. Current views of an ancient problem. Annals of Hepatology 2009;8:13-20. [DOI: 10.1016/s1665-2681(19)31805-8] [Cited by in Crossref: 59] [Article Influence: 4.9] [Reference Citation Analysis]
35 Tolman KG, Chandramouli J. Hepatotoxicity of the thiazolidinediones. Clinics in Liver Disease 2003;7:369-79. [DOI: 10.1016/s1089-3261(03)00020-5] [Cited by in Crossref: 82] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [Reference Citation Analysis]
36 Pazienza V, Clément S, Pugnale P, Conzelman S, Foti M, Mangia A, Negro F. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology. 2007;45:1164-1171. [PMID: 17465001 DOI: 10.1002/hep.21634] [Cited by in Crossref: 155] [Cited by in F6Publishing: 151] [Article Influence: 11.1] [Reference Citation Analysis]
37 Harrison SA. Liver Disease in Patients With Diabetes Mellitus. Journal of Clinical Gastroenterology 2006;40:68-76. [DOI: 10.1097/01.mcg.0000190774.91875.d2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 105] [Article Influence: 8.3] [Reference Citation Analysis]
38 Chen HF, Li CY, Chen P, See TT, Lee HY. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc. 2006;69:146-152. [PMID: 16689194 DOI: 10.1016/s1726-4901(09)70195-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
39 Blonsky JJ, Harrison SA. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime. Aliment Pharmacol Ther 2008;27:855-65. [PMID: 18315584 DOI: 10.1111/j.1365-2036.2008.03672.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
40 Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology. 2002;36:729-736. [PMID: 12198667 DOI: 10.1053/jhep.2002.35064] [Cited by in Crossref: 240] [Cited by in F6Publishing: 231] [Article Influence: 12.6] [Reference Citation Analysis]
41 Yueh C, Chen J, Lee L, Lu C, Parekh B, Chi C. Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2011;94:64-70. [DOI: 10.1016/j.diabres.2011.05.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Knobler H, Malnick S. Hepatitis C and insulin action: An intimate relationship. World J Hepatol 2016;8:131-8. [PMID: 26807209 DOI: 10.4254/wjh.v8.i2.131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
43 Gholam PM, Domingo AF. Mechanisms of glucose intolerance in patients with chronic hepatitis C: Implications for treatment. Curr Infect Dis Rep 2007;9:110-5. [DOI: 10.1007/s11908-007-0005-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Kukla M, Piotrowski D, Waluga M, Hartleb M. Insulin resistance and its consequences in chronic hepatitis C. Clin Exp Hepatol. 2015;1:17-29. [PMID: 28856251 DOI: 10.5114/ceh.2015.51375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Ndako JA, Owolabi AO, Olisa JA, Akinwumi JA, Dojumo VT, Olatinsu O, Adebayo BA. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west Nigeria. BMC Infect Dis 2020;20:664. [PMID: 32907538 DOI: 10.1186/s12879-020-05388-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Paik IJ, Kotler DP. The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection. Best Pract Res Clin Endocrinol Metab 2011;25:469-78. [PMID: 21663840 DOI: 10.1016/j.beem.2011.04.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
47 Knobler H, Schattner A. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad. QJM. 2005;98:1-6. [PMID: 15625348 DOI: 10.1093/qjmed/hci001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
48 Iroezindu MO, Isiguzo GC, Young EE. Prevalence and predictors of impaired fasting glucose among Nigerian patients with hepatitis B virus infection. Diabetes Res Clin Pract. 2012;98:338-345. [PMID: 22995732 DOI: 10.1016/j.diabres.2012.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Sorrentino P, Terracciano L, D’Angelo S, Ferbo U, Bracigliano A, Vecchione R. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. Am J Gastroenterol. 2010;105:336-344. [PMID: 19861959 DOI: 10.1038/ajg.2009.587] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
50 Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004;41:132-8. [PMID: 15246219 DOI: 10.1016/j.jhep.2004.03.020] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
51 Salmerón J. [Hepatitis C and diabetes]. Gastroenterol Hepatol 2005;28:385-7. [PMID: 16137473 DOI: 10.1157/13077769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Kotler DP. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions. Liver International 2009;29:38-46. [DOI: 10.1111/j.1478-3231.2008.01951.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
53 Kim JD, Sherker AH. Antiviral therapy: role in the management of extrahepatic diseases. Gastroenterology Clinics of North America 2004;33:693-708. [DOI: 10.1016/j.gtc.2004.04.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
54 Abdel Alem S, Elsharkawy A, Fouad R, Adel E, Abdellatif Z, Musa S, Nagy A, Hussein MS, Yosry A, Esmat G. Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience. J Med Virol. 2017;89:2181-2187. [PMID: 28688190 DOI: 10.1002/jmv.24897] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
55 Mason A, Nair S. Is type II diabetes another extrahepatic manifestation of HCV infection? Am J Gastroenterol 2003;98:243-6. [PMID: 12591036 DOI: 10.1111/j.1572-0241.2003.07269.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
56 Shen Y, Zhang S, Wang X, Wang Y, Zhang J, Qin G, Li W, Ding K, Zhang L, Liang F. Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta-analysis. Liver Int 2017;37:1451-60. [PMID: 27753241 DOI: 10.1111/liv.13275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Alberstein M, Zornitzki T, Zick Y, Knobler H. Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression. J Viral Hepat. 2012;19:65-71. [PMID: 22187946 DOI: 10.1111/j.1365-2893.2011.01447.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
58 Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol. 2006;101:2629-2640. [PMID: 16952281 DOI: 10.1111/j.1572-0241.2006.00848.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 114] [Article Influence: 8.1] [Reference Citation Analysis]
59 Strauhs-Nitsch L, Campiolo MF, Morsoletto DBG, Pissaia Junior A, Ivantes CAP. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR. Arq Gastroenterol 2020;57:267-71. [PMID: 33027477 DOI: 10.1590/S0004-2803.202000000-50] [Reference Citation Analysis]
60 Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009;7:293-308. [PMID: 19344243 DOI: 10.1586/eri.09.3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
61 Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol. 2017;23:1697-1711. [PMID: 28321170 DOI: 10.3748/wjg.v23.i9.1697] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
62 Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver Int 2008;28:355-62. [PMID: 18290778 DOI: 10.1111/j.1478-3231.2007.01630.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
63 Elhawary EI, Mahmoud GF, El-Daly MA, Mekky FA, Esmat GG, Abdel-Hamid M. Association of HCV with diabetes mellitus: an Egyptian case-control study. Virol J. 2011;8:367. [PMID: 21791087 DOI: 10.1186/1743-422x-8-367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
64 Yazicioglu G, Isitan F, Altunbas H, Suleymanlar I, Ozdogan M, Balci MK, Karayalcin U. Insulin resistance in chronic hepatitis C. Int J Clin Pract. 2004;58:1020-1022. [PMID: 15605664 DOI: 10.1111/j.1742-1241.2004.00170.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
65 Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y. Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne). 2015;6:134. [PMID: 26441826 DOI: 10.3389/fendo.2015.00134] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
66 Chehadeh W, Al-Nakib W. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy. J Med Virol 2009;81:610-8. [PMID: 19235842 DOI: 10.1002/jmv.21396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
67 Arturo Kobashi-margáin R, Gutiérrez-grobe Y, Ponciano-rodríguez G, Uribe M, Méndez-sánchez N. Prevalence of type 2 diabetes mellitus and chronic liver disease: A retrospective study of the association of two increasingly common diseases in Mexico. Annals of Hepatology 2010;9:282-8. [DOI: 10.1016/s1665-2681(19)31638-2] [Cited by in Crossref: 10] [Article Influence: 0.9] [Reference Citation Analysis]
68 Zuwała-Jagiello J, Pazgan-Simon M, Simon K, Warwas M. Picolinic acid in patients with chronic hepatitis C infection: a preliminary report. Mediators Inflamm 2012;2012:762863. [PMID: 22701277 DOI: 10.1155/2012/762863] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
69 Lecube A, Hernández C, Simó R. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. Diabetes Metab Res Rev 2009;25:403-10. [PMID: 19444865 DOI: 10.1002/dmrr.972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
70 Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res. 2007;38:621-627. [PMID: 17613353 DOI: 10.1016/j.arcmed.2006.09.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
71 Greca LF, Pinto LC, Rados DR, Canani LH, Gross JL. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz J Med Biol Res 2012;45:284-90. [PMID: 22286533 DOI: 10.1590/s0100-879x2012007500013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
72 Moucari R, Marcellin P, Asselah T. Stéatose au cours de l’hépatite chronique C : rôle de l’insulino-résistance et des facteurs viraux. Gastroentérologie Clinique et Biologique 2007;31:643-54. [DOI: 10.1016/s0399-8320(07)91911-9] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
73 Craxì A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med. 2008;29:85-95. [PMID: 18177700 DOI: 10.1016/j.mam.2007.09.017] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
74 Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study. J Viral Hepat 2009;16:430-6. [PMID: 19200136 DOI: 10.1111/j.1365-2893.2009.01077.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
75 Ocak S, Duran N, Kaya H, Emir I. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. Int J Clin Pract. 2006;60:670-674. [PMID: 16805751 DOI: 10.1111/j.1368-5031.2006.00738.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
76 Ratziu V, Heurtier A, Bonyhay L, Poynard T, Giral P. Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link. Aliment Pharmacol Ther. 2005;22 Suppl 2:56-60. [PMID: 16225475 DOI: 10.1111/j.1365-2036.2005.02598.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
77 Cross TJS, Rashid MM, Berry PA, Harrison PM. The importance of steatosis in chronic hepatitis C infection and its management: A review. Hepatology Research 2010;40:237-47. [DOI: 10.1111/j.1872-034x.2010.00626.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
78 Oliveira AC, Parise ER, Catarino RM, Lanzoni V, Leite-Mor MM, Simon KA, Junqueira VB. Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype. Free Radic Res 2009;43:1187-94. [PMID: 19905981 DOI: 10.3109/10715760903247249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
79 Drazilova S, Gazda J, Janicko M, Jarcuska P. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy. Can J Gastroenterol Hepatol 2018;2018:6150861. [PMID: 30186821 DOI: 10.1155/2018/6150861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
80 Serfaty L, Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009;29 Suppl 2:13-25. [PMID: 19187069 DOI: 10.1111/j.1478-3231.2008.01952.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
81 Atabek ME, Kart H, Erkul I. Prevalence of hepatitis A, Β, C and Ε virus in adolescents with type-1 diabetes mellitus. International Journal of Adolescent Medicine and Health 2003;15. [DOI: 10.1515/ijamh.2003.15.2.133] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol. 2012;18:1642-1651. [PMID: 22529694 DOI: 10.3748/wjg.v18.i14.1642] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 76] [Article Influence: 9.8] [Reference Citation Analysis]
83 Huang JF, Yu ML, Dai CY, Hsieh MY, Hwang SJ, Hsiao PJ, Lee LP, Lin ZY, Chen SC, Hsieh MY. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection. Am J Gastroenterol. 2008;103:1933-1940. [PMID: 18637090 DOI: 10.1111/j.1572-0241.2008.01996.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
84 Yoneda M, Saito S, Ikeda T, Fujita K, Mawatari H, Kirikoshi H, Inamori M, Nozaki Y, Akiyama T, Takahashi H, Abe Y, Kubota K, Iwasaki T, Terauchi Y, Togo S, Nakajima A. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepat 2007;14:600-7. [DOI: 10.1111/j.1365-2893.2006.00836.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
85 Nwankiti OO, Ndako JA, Echeonwu GO, Olabode AO, Nwosuh CI, Onovoh EM, Okeke LA, Akinola JO, Duru BN, Nwagbo IO, Agada GO, Chukwuedo AA. Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J 2009;6:110. [PMID: 19619316 DOI: 10.1186/1743-422X-6-110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005;100:1509-15. [PMID: 15984973 DOI: 10.1111/j.1572-0241.2005.41403.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 10.1] [Reference Citation Analysis]
87 Furutani M, Nakashima T, Sumida Y, Hirohama A, Yoh T, Kakisaka Y, Mitsuyoshi H, Senmaru H, Okanoue T. Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection. Liver Int. 2003;23:294-299. [PMID: 12895270 DOI: 10.1034/j.1600-0676.2003.00841.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
88 Shurman DL, Benedetto AV. Antimicrobials in dermatologic surgery: Facts and controversies. Clinics in Dermatology 2010;28:505-10. [DOI: 10.1016/j.clindermatol.2010.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
89 Marzouk D, Sass J, Bakr I, El Hosseiny M, Abdel-Hamid M, Rekacewicz C, Chaturvedi N, Mohamed MK, Fontanet A. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007;56:1105-1110. [PMID: 16956918 DOI: 10.1136/gut.2006.091983] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
90 Walsh MJ, Jonsson JR, Richardson MM, Lipka GM, Purdie DM, Clouston AD, Powell EE. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 2006;55:529-35. [PMID: 16299039 DOI: 10.1136/gut.2005.069674] [Cited by in Crossref: 204] [Cited by in F6Publishing: 196] [Article Influence: 12.8] [Reference Citation Analysis]
91 Duong M, Petit JM, Piroth L, Grappin M, Buisson M, Chavanet P, Hillon P, Portier H. Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral Therapy: . Journal of Acquired Immune Deficiency Syndromes 2001;27:245-50. [DOI: 10.1097/00042560-200107010-00005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
92 Hsu CS, Liu CJ, Liu CH, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH. Metabolic profiles in patients with chronic hepatitis C: a case-control study. Hepatol Int 2008;2:250-7. [PMID: 19669312 DOI: 10.1007/s12072-008-9064-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
93 Andrade VG, Yamashiro FDS, Oliveira CV, Moreira A, Winckler FC, Silva GF. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES. Arq Gastroenterol 2018;55:274-8. [PMID: 30540091 DOI: 10.1590/S0004-2803.201800000-69] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
94 Imafuku S, Naito R, Nakayama J. Possible association of hepatitis C virus infection with late-onset psoriasis: A hospital-based observational study. J Dermatol 2013. [DOI: 10.1111/1346-8138.12240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
95 Nevola R, Acierno C, Pafundi PC, Adinolfi LE. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Med 2021;112:188-200. [PMID: 33205641 DOI: 10.23736/S0026-4806.20.07129-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ozdemir A, Yalinbas B, Selamet U, Eres M, Turkmen F, Kumbasar F, Murat B, Keskin AT, Barut Y. The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients. Yonsei Med J 2007;48:274-80. [PMID: 17461527 DOI: 10.3349/ymj.2007.48.2.274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
97 Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology. 2003;125:1695-1704. [PMID: 14724822 DOI: 10.1053/j.gastro.2003.08.032] [Cited by in Crossref: 503] [Cited by in F6Publishing: 474] [Article Influence: 29.6] [Reference Citation Analysis]
98 Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, Poynard T. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol. 2006;44:S19-S24. [PMID: 16356583 DOI: 10.1016/j.jhep.2005.11.009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 8.3] [Reference Citation Analysis]
99 Reddy KR, Govindarajan S, Marcellin P, Bernstein D, Dienstag JL, Bodenheimer H Jr, Rakela J, Messinger D, Schmidt G, Ackrill A, Hadziyannis SJ. Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat. 2008;15:129-136. [PMID: 18184196 DOI: 10.1111/j.1365-2893.2007.00901.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
100 Parolin MB, Réa R, Vargas RM, de Almeida AC, Baldanzi GR, Lopes RW. [Prevalence of hepatitis C infection in patients with type 2 diabetes mellitus]. Arq Gastroenterol 2006;43:77-80. [PMID: 17119658 DOI: 10.1590/s0004-28032006000200003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
101 Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, Tolkoff-Rubin N, Pascual M. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001;72:1066-1072. [PMID: 11579302 DOI: 10.1097/00007890-200109270-00015] [Cited by in Crossref: 216] [Cited by in F6Publishing: 177] [Article Influence: 10.8] [Reference Citation Analysis]
102 Ciria R, Pleguezuelo M, Khorsandi SE, Davila D, Suddle A, Vilca-Melendez H, Rufian S, de la Mata M, Briceño J, Cillero PL, Heaton N. Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol 2013;5:237-50. [PMID: 23717735 DOI: 10.4254/wjh.v5.i5.237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
103 Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat. 2006;13:303-310. [PMID: 16637860 DOI: 10.1111/j.1365-2893.2005.00677.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 4.8] [Reference Citation Analysis]
104 El-serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans: Extrahepatic Manifestations of Hepatitis C Among United States Male Veterans. Hepatology 2002;36:1439-45. [DOI: 10.1002/hep.1840360621] [Cited by in Crossref: 133] [Cited by in F6Publishing: 67] [Article Influence: 9.5] [Reference Citation Analysis]
105 Omar Jáquez Quintana J, García-compean D, Alberto González González J, Zacarías Villarreal Pérez J, Javier Lavalle González F, Elsa Muñoz Espinosa L, López Hernández P, Reyes Cabello E, Redondo Villarreal E, Flores Rendón R, Maldonado Garza H. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Annals of Hepatology 2011;10:56-62. [DOI: 10.1016/s1665-2681(19)31588-1] [Cited by in Crossref: 36] [Article Influence: 3.6] [Reference Citation Analysis]
106 Rosenthal E, Cacoub P. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus. 2015;24:469-482. [PMID: 25801890 DOI: 10.1177/0961203314556140] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
107 Persico M, Masarone M, La Mura V, Persico E, Moschella F, Svelto M, Bruno S, Torella R. Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol 2009;15:462-6. [PMID: 19152451 DOI: 10.3748/wjg.15.462] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
108 Shlomai A, Rechtman MM, Burdelova EO, Zilberberg A, Hoffman S, Solar I, Fishman S, Halpern Z, Sklan EH. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance. J Hepatol. 2012;57:867-873. [PMID: 22732512 DOI: 10.1016/j.jhep.2012.06.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
109 Montano-Loza AJ, Sultan A, Falanga D, Loss G, Mason AL. Immunogenetic susceptibility to diabetes mellitus in patients with liver disease. Liver Int 2009;29:1543-51. [PMID: 19663932 DOI: 10.1111/j.1478-3231.2009.02095.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
110 Negro F. Insulin resistance and HCV: will new knowledge modify clinical management? J Hepatol 2006;45:514-9. [PMID: 16901576 DOI: 10.1016/j.jhep.2006.07.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
111 Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications. 2006;20:113-120. [PMID: 16504840 DOI: 10.1016/j.jdiacomp.2006.01.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
112 Lonardo A, Loria P, Carulli N. Dysmetabolic changes associated with HCV: a distinct syndrome? Intern Emerg Med. 2008;3:99-108. [PMID: 18274709 DOI: 10.1007/s11739-008-0127-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
113 Coppo C, Bonfanti D, Bo S, Giordanino C, Gallo M, Cococcia S, Ciccone G, Smedile A, Ciancio A, Bugianesi E, Fagoonee S, Pellicano R, Rizzetto M, Saracco GM. Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study. Digestive and Liver Disease 2015;47:405-10. [DOI: 10.1016/j.dld.2015.01.157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
114 Persico M, Masarone M, La Mura V, Persico E, Moschella F, Svelto M, Bruno S, Torella R. Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol 2009;15:462-6. [PMID: 19152451 DOI: 10.3748/wjg.15.462] [Reference Citation Analysis]
115 Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study. Liver Transpl. 2007;13:136-144. [PMID: 17192854 DOI: 10.1002/lt.21010] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 7.3] [Reference Citation Analysis]
116 Duong M, Petit JM, Piroth L, Grappin M, Buisson M, Chavanet P, Hillon P, Portier H. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy. J Acquir Immune Defic Syndr 2001;27:245-50. [PMID: 11464143 DOI: 10.1097/00126334-200107010-00005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
117 Babudieri S, Soddu A, Nieddu P, Tanca A, Madeddu G, Addis M, Pagnozzi D, Cossu-rocca P, Massarelli G, Dore M, Uzzau S, Mura M. Proteomic characterization of hepatitis C eradication: Enzyme switch in the healing liver. Journal of Clinical Virology 2013;57:274-8. [DOI: 10.1016/j.jcv.2013.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
118 Park SH, Kim DJ, Lee HY. Insulin Resistance Is Not Associated With Histologic Severity in Nondiabetic, Noncirrhotic Patients With Chronic Hepatitis B Virus Infection. Am J Gastroenterol 2009;104:1135-9. [DOI: 10.1038/ajg.2009.6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
119 Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB;  Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39:2-17. [PMID: 16884964 DOI: 10.1016/j.dld.2006.06.008] [Cited by in Crossref: 164] [Cited by in F6Publishing: 142] [Article Influence: 10.9] [Reference Citation Analysis]
120 Zignego AL, Craxì A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis. 2008;12:611-636, ix. [PMID: 18625431 DOI: 10.1016/j.cld.2008.03.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
121 Modaresi Esfeh J, Ansari-Gilani K. Steatosis and hepatitis C. Gastroenterol Rep (Oxf) 2016;4:24-9. [PMID: 26276502 DOI: 10.1093/gastro/gov040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
122 Cheng AY, Kong AP, Wong VW, So WY, Chan HL, Ho CS, Lam CW, Tam JS, Chow CC, Cockram CS. Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia. 2006;49:1777-1784. [PMID: 16736132 DOI: 10.1007/s00125-006-0294-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
123 Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology. 2003;38:1384-1392. [PMID: 14647049 DOI: 10.1016/j.hep.2003.09.012] [Cited by in Crossref: 158] [Cited by in F6Publishing: 162] [Article Influence: 8.8] [Reference Citation Analysis]
124 Puri P, Sanyal AJ. Role of Obesity, Insulin Resistance, and Steatosis in Hepatitis C Virus Infection. Clinics in Liver Disease 2006;10:793-819. [DOI: 10.1016/j.cld.2006.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
125 Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int. 2008;28:271-277. [PMID: 18028320 DOI: 10.1111/j.1478-3231.2007.01626.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
126 Sène D, Saadoun D, Limal N, Piette JC, Cacoub P. [Update in Hepatitis C virus associated extrahepatic manifestations]. Rev Med Interne 2007;28:388-93. [PMID: 17137683 DOI: 10.1016/j.revmed.2006.10.321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
127 Mason A. Viral Induction of Type 2 Diabetes and Autoimmune Liver Disease. The Journal of Nutrition 2001;131:2805S-8S. [DOI: 10.1093/jn/131.10.2805s] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Douglas MW, George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol 2009;15:4356-64. [PMID: 19764085 DOI: 10.3748/wjg.15.4356] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
129 Chehadeh W, Sarkhouh HA, Al-nakib W. Predictors of glucose intolerance in HCV-infected patients with no family history of diabetes. Diabetes Research and Clinical Practice 2007;77:157-8. [DOI: 10.1016/j.diabres.2006.10.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
130 Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol. 2005;100:48-55. [PMID: 15654780 DOI: 10.1111/j.1572-0241.2005.40429.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 5.8] [Reference Citation Analysis]
131 Lorho R, Hardwigsen J, Dumortier J, Pageaux GP, Durand F, Bizollon T, Blanc AS, Di Giambattista F, Duvoux C. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study. Clin Res Hepatol Gastroenterol. 2011;35:482-488. [PMID: 21530445 DOI: 10.1016/j.clinre.2011.03.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
132 Marchetti P. New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl. 2005;11:612-620. [PMID: 15915488 DOI: 10.1002/lt.20439] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
133 Elgouhari HM, Zein CO, Hanouneh I, Feldstein AE, Zein NN. Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection. Dig Dis Sci. 2009;54:2699-2705. [PMID: 19148751 DOI: 10.1007/s10620-008-0683-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
134 Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep. 2004;4:194-198. [PMID: 15132884 DOI: 10.1007/s11892-004-0023-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
135 Rouabhia S, Malek R, Bounecer H, Dekaken A, Bendali Amor F, Sadelaoud M, Benouar A. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol 2010;16:3427-31. [PMID: 20632447 DOI: 10.3748/wjg.v16.i27.3427] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
136 Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol. 2001;35:279-283. [PMID: 11580152 DOI: 10.1016/s0168-8278(01)00143-x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
137 García-Compeán D, Jáquez-Quintana JO, González-González JA, Lavalle-González FJ, Villarreal-Pérez JZ, Maldonado-Garza HJ. [Diabetes in liver cirrhosis]. Gastroenterol Hepatol 2013;36:473-82. [PMID: 23628170 DOI: 10.1016/j.gastrohep.2013.01.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
138 Weinman SA, Belalcazar LM. Hepatitis C: a metabolic liver disease. Gastroenterology. 2004;126:917-919. [PMID: 14988846 DOI: 10.1053/j.gastro.2003.01.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
139 Yldz A, T??t??nc?? Y, Yazc H, Akkaya V, Mehmet Kayacan S, ????kr?? Sever M, ??arin M, Kar??da?? K. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients12: . Transplantation 2002;74:1109-13. [DOI: 10.1097/00007890-200210270-00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
140 Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM, Jonsson JR. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol. 2003;39:1042-1048. [PMID: 14642624 DOI: 10.1016/s0168-8278(03)00463-x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
141 Li X, Jiao Y, Xing Y, Gao P. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. Biomed Res Int. 2019;2019:5308308. [PMID: 31080822 DOI: 10.1155/2019/5308308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
142 Chen YW, Chen HH, Wang TE, Chang CW, Chang CW, Chen WC, Wu CJ. The dissociation between the diabetes and both Child-Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic. Hepatol Int. 2011;5:955-964. [PMID: 21505947 DOI: 10.1007/s12072-011-9274-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
143 Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23:779-782. [PMID: 18028349 DOI: 10.1038/sj.ijo.0803204] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 6.9] [Reference Citation Analysis]
144 Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect. 2005;50:331-337. [PMID: 15845431 DOI: 10.1016/j.jinf.2004.06.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
145 Huang JF, Dai CY, Hwang SJ, Ho CK, Hsiao PJ, Hsieh MY, Lee LP, Lin ZY, Chen SC, Wang LY, Shin SJ, Chang WY, Chuang WL, Yu ML. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol. 2007;102:1237-1243. [PMID: 17531012 DOI: 10.1111/j.1572-0241.2007.01181.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
146 Watt GP, Vatcheva KP, Beretta L, Pan JJ, Fallon MB, McCormick JB, Fisher-Hoch SP. Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes. Epidemiol Infect 2016;144:297-305. [PMID: 26088260 DOI: 10.1017/S0950268815001247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
147 Friedenberg F, Pungpapong S, Zaeri N, Braitman LE. The impact of diabetes and obesity on liver histology in patients with hepatitis C. Diabetes Obes Metab 2003;5:150-5. [PMID: 12681021 DOI: 10.1046/j.1463-1326.2003.00256.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
148 Zhang J, Shen Y, Cai H, Liu Y, Qin G. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta-analysis: HBV infection status and risk of T2DM. Hepatol Res 2015;45:1100-9. [DOI: 10.1111/hepr.12481] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
149 Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med. 2007;120:829-834. [PMID: 17904449 DOI: 10.1016/j.amjmed.2007.03.025] [Cited by in Crossref: 97] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
150 Buresi MC, Lee J, Gill S, Kong JM, Money DM, Yoshida EM; Hepatitis C vertical Transmission Study Group. The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia. J Obstet Gynaecol Can 2010;32:935-41. [PMID: 21176301 DOI: 10.1016/s1701-2163(16)34680-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
151 Chehadeh W, Abdella N, Ben-Nakhi A, Al-Arouj M, Al-Nakib W. Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection. J Gastroenterol Hepatol. 2009;24:42-48. [PMID: 18717762 DOI: 10.1111/j.1440-1746.2008.05503.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
152 Ratziu V, Trabut JB, Poynard T. Fat, diabetes, and liver injury in chronic hepatitis C. Curr Gastroenterol Rep. 2004;6:22-29. [PMID: 14720450 DOI: 10.1007/s11894-004-0022-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
153 Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, Heaton ND, O’Grady JG. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2006;6:1922-1929. [PMID: 16780550 DOI: 10.1111/j.1600-6143.2006.01408.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 6.7] [Reference Citation Analysis]
154 Sène D, Limal N, Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 2004;19:357-81. [PMID: 15554428 DOI: 10.1023/b:mebr.0000043982.17294.9b] [Cited by in Crossref: 81] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
155 Dai CY, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol. 2009;50:712-718. [PMID: 19231011 DOI: 10.1016/j.jhep.2008.12.017] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 9.4] [Reference Citation Analysis]
156 Lao TT, Chan BC, Leung WC, Ho LF, Tse KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007;47:46-50. [PMID: 17434231 DOI: 10.1016/j.jhep.2007.02.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
157 Sjöberg K, Widell A, Verbaan H. Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers. Eur J Gastroenterol Hepatol. 2008;20:135-138. [PMID: 18188035 DOI: 10.1097/meg.0b013e3282f476f5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
158 Howard AA, Klein RS, Schoenbaum EE. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis. 2003;36:1318-1323. [PMID: 12746779 DOI: 10.1086/374838] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
159 Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol. 2016;22:9674-9693. [PMID: 27956792 DOI: 10.3748/wjg.v22.i44.9674] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 56] [Article Influence: 16.3] [Reference Citation Analysis]
160 Chehadeh W, Kurien SS, Abdella N, Ben-Nakhi A, Al-Arouj M, Almuaili T, Al-Mutairi O, Al-Nakib W. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. J Infect Public Health. 2011;4:200-206. [PMID: 22000848 DOI: 10.1016/j.jiph.2011.05.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
161 Li-ng M, Tropp S, Danoff A, Bini E. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Digestive and Liver Disease 2007;39:549-56. [DOI: 10.1016/j.dld.2007.02.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
162 Huang JF, Huang CF, Yeh ML, Dai CY, Yu ML, Chuang WL. Updates in the management and treatment of HCV genotype 3, what are the remaining challenges? Expert Rev Anti Infect Ther. 2018;16:907-912. [PMID: 30396303 DOI: 10.1080/14787210.2018.1544492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]